Tirzepatide is a dual GIP/GLP-1 receptor agonist, which the platform describes as its compounded alternative to Zepbound and Mounjaro
Ipamorelin was derived through medicinal-chemistry simplification of the GHRP-1, GHRP-2, GHRP-6, and Hexarelin series at Novo Nordisk in the mid-1990s
In this context, aspects, such as the medium composition (amino acids, alternative raw materials) and the use of technological approaches (control of osmotic and pressure conditions, magnetic field (MF) application, fed-batch process) were considered, along with genetic engineering knowledge, trends, and challenges in viable GSH production
Wegovy (Semaglutide Injection) Wegovy is the weight loss cousin to Ozempic, sharing the active ingredient semaglutide